Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Caribou Biosciences (CRBU) Debt to Equity: 2020

  • Caribou Biosciences' Debt to Equity was N/A to -$0.04 in Q4 2020 from the same period last year, while for Dec 2020 it was -$0.04, marking a year-over-year change of. This contributed to the annual value of -$0.04 for FY2020, which is N/A change from last year.
  • According to the latest figures from Q4 2020, Caribou Biosciences' Debt to Equity is -$0.04.
  • In the past 5 years, Caribou Biosciences' Debt to Equity registered a high of -$0.04 during Q4 2020, and its lowest value of -$0.04 during Q4 2020.
  • Over the past 1 years, Caribou Biosciences' median Debt to Equity value was -$0.04 (recorded in 2020), while the average stood at -$0.04.